Fund house had extended moratorium to group companies on April-June obligations
The Sensex rose 606 points, or 1.9%, to end at 32,720 - the highest close since March 13
In the past 1-2 years, Emami has seen muted volume off-take, thanks to higher dependence on wholesale distribution and competitive pressures
Even as costs are lower, demand weakness likely to keep airlines in the red for most of FY21
The rebalancing is scheduled to take place on May 12 and the changes will become effective from June 1
Thus far in CY20, 20 companies have announced buyback of their shares, of which, 14 firms have proposed to buyback from open market route
Banks may look at conserving capital, with asset quality concerns rising amid Coronavirus-induced lockdown
Investors exposed to dynamic accrual fund can see shorter timeframe, as 45% of the assets are maturing within two years
The worst-case scenario, assumes that coronavirus (Covid-19) will continue to spread, possibly in waves, all the way through to mid-2021
The Wall Street bank expects benchmark US oil prices to stabilise at around $40 a barrel next year
Lenders say the larger challenge is to communicate to borrowers the difference between moratorium and waiver
Among sectoral indices, Nifty Metal index was the top gainer - up 3.74 per cent at 1,724 levels, followed by Nifty Financial Service index (up 3.43 per cent)
All that happened in the markets today
Ruchi Soya stands ahead of Dalmia Bharat, GMR Infrastructure, Polycab India, Crisil, Cummins India, IDFC First Bank, ICICI Securities, and Tata Communications in the m-cap ranking.
So far, information technology (IT) companies have reported a mixed set of numbers for the quarter ended March 2020.
Last week, Deepak Phenolics, a wholly-owned subsidiary of the company, commenced commercial production of Isopropyl Alcohol at its manufacturing facility situated at Dahej, Gujarat.
The stock surpassed its previous high of Rs 316.80, touched on February 27, 2020
Companies with higher exposure to food and daily essentials, analysts say, are expected to fare better this quarter as compared to those with a skew towards discretionary consumption
The drug has demonstrated positive outcomes, including a reduction in the duration of Covid-19 and improved lung conditions for the patients
Historically, Q4 is the first time since March 2018 that the bank has dipped into losses of this magnitude because of the provisioning cost